Jun 29, 2024
Mutant generation in Streptococcus oralis strain S.mitis/oralis 351
- Samantha King1
- 1Nationwide Children's Hospital
Protocol Citation: Samantha King 2024. Mutant generation in Streptococcus oralis strain S.mitis/oralis 351. protocols.io https://dx.doi.org/10.17504/protocols.io.261ge5wpog47/v1
License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Protocol status: Working
We use this protocol and it's working
Created: June 28, 2024
Last Modified: June 29, 2024
Protocol Integer ID: 102530
Keywords: Transformation, mutagenesis, mutant generation in streptococcus orali, insertion deletion mutants in streptococcus orali, insertion deletion mutants in streptococcus, mutant generation in streptococcus, streptococcus orali, insertion deletion mutant, streptococcus, mutant generation
Funders Acknowledgements:
American Heart Association
Grant ID: 19TPA34760750
Abstract
This protocol is the methodology that we have successfully employed to generate and confirm insertion deletion mutants in Streptococcus oralis strain S.mitis/oralis 351. Attached to the protocol is a file that includes primers for the srtA mutation
Attachments
Materials
| A | B | C | D | |
| Target | Name | Sequence 5’ to 3’ | Location (accession no.) | |
| Spec | S1 | CGATTTTCGTTCGTGAATAC | 5418–5399 (KM009065) | |
| S2 | TATGCAAGGGTTTATTGTTTTC | 4265–4286 (KM009065) | ||
| pDrive | M13F | GTAAAACGACGGCCAG | 432-447 (DQ996013.1) | |
| M13R | CAGGAAACAGCTATGAC | 204-220 (DQ996013.1) |
Safety warnings
Appropriate biosafety procedures need to be followed
Mutant generation in Streptococcus oralis strain S.mitis/oralis 351
Creation of a plasmid construct
The regions upstream and downstream of the region to be deleted were amplified
using primers 1 and 2, and 3 and 4, respectively. These primers were designed
to contain appropriate overhangs to allow In-fusion with pJET 1.2/blunt and the
antibiotic resistance cassette.
The spectinomycin resistance cassette (aad9) was amplified using
primers S1 and S2
PCR products were then purified with a Qiagen PCR Purification Kit
The three fragments for each mutant construct were cloned into pDRIVE using In-Fusion Snap Assembly (Takara) and transformed into Escherichia coli stellar competent cells.
Transformants were selected on LB agar plates supplemented with ampicillin (100 µg/ml) and incubated at 37oC overnight
The resulting colonies were confirmed as ampicillin resistant by streaking on a new LB agar plate supplemented with ampicillin (100 µg/ml).
Transformants were screened by colony PCR using M13 Forward and Reverse primers.
For transformants giving an appropriate PCR product, a 5 mL LB culture supplemented with ampicillin (100 µg/ml) was grown overnight at 37 °C with shaking at 200 rpm.
The plasmid was then purified using Qiagen Miniprep Kit and confirmed by sequencing
Transformation of S. mitis B6
Strains were growth at 37°C in C+Y pH8 [1] – starting at a low inoculum i.e. from a plate or diluting from a culture 1:100 (starting optical density at 600nm [OD600] = 0.03 to 0.05).
When the culture was close to OD600 =0.1, 950 μl of C+Y pH 8.0 medium was added to a 1.5 ml tube with 10 μl of 100 mM CaCl2, 2 μl of competence stimulating peptide (CSP) (DKRLPYFFKHLFSNRTK - 1 mg/ml), and 150 ng of DNA. A no DNA control tube is included as a negative control. These tubes were prewarmed in a waterbath to 37°C.
When the culture reached an OD600 of 0.12, 50 μl of culture was added to the prewarmed tubes.
Tubes were incubated in a waterbath at 37 °C for 2 hr.
Reactions were pelleted by centrifugation and resuspended in approximately 100 µl of media. This was plated on selective Tryptic Soy Agar (TSA) plates spread with 5000 U catalase (Worthington Biochemical Corporation).
Plates were incubated at 37oC in 5% CO2 overnight and then patched onto selective plates.
Confirmation of putative transformants
Putative transformants were grown in tryptic soy broth and DNA prepared as previously described [2].
The mutations were confirmed by PCR and sequencing (using primers 5 and 6). Genetic background was confirmed by repetitive extragenic palindromic PCR [3].
Protocol references
1. LACKS S, HOTCHKISS RD. A study of the
genetic material determining an enzyme in Pneumococcus. Biochim Biophys Acta.
1960;39:508-18. doi: 10.1016/0006-3002(60)90205-5. PubMed PMID: 14413322.
2. Gaytán MO, Singh AK, Woodiga SA, Patel
SA, An SS, Vera-Ponce de León A, et al. A novel sialic acid-binding adhesin
present in multiple species contributes to the pathogenesis of Infective
endocarditis. PLoS Pathog. 2021;17(1):e1009222. Epub 20210119. doi:
10.1371/journal.ppat.1009222. PubMed PMID: 33465168; PubMed Central PMCID:
PMCPMC7846122.
3. Alam S, Brailsford SR, Whiley RA, Beighton D. PCR-Based methods for genotyping viridans group
streptococci. J Clin Microbiol. 1999; 37(9):2772–6. https://doi.org/10.1128/JCM.37.9.2772-2776.1999
PMID: 10449450